PATENTS

1988    
Co-Founder of CoCensys, a biotechnology corporation for the development of ethical pharmaceuticals to treat neurological and psychiatric disorders. CoCensys was acquired by Purdue Pharma.
 
1992
US Patent 5,120,723. Issued June 9, 1992. Compositions and methods for alleviating stress, anxiety and seizure activity. Inventors: Gee KW, Bolger MD, Brinton RE, Burke, DJ, McEwen BS.
 
1993    
US Patent 5,232,917. Issued May 4, 1993. Methods, compositions, and compounds modulating brain excitability. Inventors: Gee KW, Bolger MD, Brinton RE, Burke, DJ, McEwen BS.
 
2013    
US Patent 8552057. Issued October 8, 2013 “Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases. Inventors: Brinton RD, Zhao L. Filed  January 31, 2012
 
2014    
US Patent 8680140.  Issued March 25, 2014 “Phytoestrogenic formulations for alleviation menopausal symptoms. Inventors: Brinton RD, Zhao L. Filed October 26, 2009
 
2014  
Australia Patent 2010308308. Issued March 13, 2014, “Neuroprotection and Myelin Repair Using Nestorone,” Inventors: Sitruk-Ware R, Schumacher M, Brinton RD, El-Etr, Ghoumari M and Guennoun. Filed October 19, 2010.
 
2015    
US Patent 8969329  Issued March 3, 2015 “Allopregnanolone in a Method for Enhancing Neurological Function (Alzheimer's Disease)” Inventors: Brinton RD, Wang JM. Filed June 11, 2008.

2015  
Canadian Patent 2777551. Issued December 22, 2015. “Neuroprotection and Myelin Repair Using Nestorone,” Inventors: Sitruk-Ware R, Schumacher M, Brinton RD, El-Etr, Ghoumari M and Guennoun. Filed October 19, 2010.
 
2016  
Japan Patent allowed Issued TBA. “Neuroprotection and Myelin Repair Using Nestorone,” Inventors: Sitruk-Ware R, Schumacher M, Brinton RD, El-Etr, Ghoumari M and Guennoun. Filed October 19, 2010.